TRDA

Entrada Therapeutics, Inc.

3 catalysts on file

TRDA

Entrada Therapeutics, Inc.

Phase 1 Confirmed

ENTR-601-44

Duchenne muscular dystrophy

60d ago May 7, 2026

SEC 8-K verified 13h ago

TRDA

Entrada Therapeutics, Inc.

Phase 2 Confirmed

ENTR-601-44

Duchenne muscular dystrophy

60d ago May 7, 2026

SEC 8-K verified 12h ago

TRDA

Entrada Therapeutics, Inc.

Phase 2 AI-extracted

ENTR-601-45

Duchenne muscular dystrophy

T-minus 56 days ~ Aug 31, 2026

SEC 8-K verified 13h ago